Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1519670 (
tumor angiogenesis
)
6,052
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Angiogenesis is essential for cardiac functional recovery after myocardial infarction (MI).
HSPA12B
is predominately expressed in endothelial cells and required for angiogenesis. Yes-associated protein (YAP) plays an important role in
tumor angiogenesis
. This study investigated the cooperative role of
HSPA12B
and YAP in angiogenesis after MI. Silencing of either
HSPA12B
or YAP impaired hypoxia-promoted endothelial cell proliferation and angiogenesis. Deficiency of
HSPA12B
suppressed YAP expression and nuclear translocation after hypoxia. Knockdown of YAP attenuated hypoxia-stimulated
HSPA12B
nuclear translocation and abrogated
HSPA12B
-promoted endothelial cell angiogenesis. Mechanistically, hypoxia induced an interaction between endothelial
HSPA12B
and YAP. ChIP assay showed that
HSPA12B
is a target gene of YAP/transcriptional enhanced associated domain 4 (TEAD4) and a coactivator in YAP-associated angiogenesis. In vivo studies using the MI model showed that endothelial cell-specific deficiency of
HSPA12B
(eHspa12b-/-) or YAP (eYap-/-) impaired angiogenesis and exacerbated cardiac dysfunction compared with WT mice. MI increased YAP expression and nuclear translocation in WT hearts but not eHspa12b-/- hearts.
HSPA12B
expression and nuclear translocation were upregulated in WT MI hearts but not eYap-/- MI myocardium. Our data demonstrate that endothelial
HSPA12B
is a target and coactivator for YAP/TEAD4 and cooperates with YAP to regulate endothelial angiogenesis after MI.
...
PMID:Endothelial cell HSPA12B and yes-associated protein cooperatively regulate angiogenesis following myocardial infarction. 3279 Jun 47